Being developed as a potential treatment for both pandemic avian and seasonal influenza A infections, CC-42344 claims to have demonstrated 'excellent' in vitro antiviral activity against a range ...

Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ...

Although more than 100 people have been infected by H5N1 influenza A viruses, human-to-human transmission is rare 1. What are the molecular barriers limiting human-to-human transmission?

RNAi-based sequence-specific therapeutic agents can maintain pace with the high rate of mutation of influenza virus and HIV, there is a great potential for such therapeutic agents in the near future.

The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...

In the near future, gene silencing against influenza viruses may also be successfully applied in antiviral therapeutics. There are several bottlenecks in the successful application of gene ...